Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by bluemoons20on Nov 18, 2021 11:38am
131 Views
Post# 34141056

RE:Interesting

RE:InterestingSeems like a reasonable assumption at the end of the article.  Lots of activity in AI.  choice is to try to  buy  some existing  situation  or start from scratch and develop  your own.

Guess the  option chosen would depend  on the quality of the available option  and  the  price.

If it was deemed cheaper to 'do it yourself'  , then  that would  be the choice   with the other factor being  time.  buying off the shelf  now  might still be cheaper  since  time to develop  means potential lost opportunity cost.

Still raises the question  - how good is VPT actual product?  Free give aways  at some key hospitals does provide  exposure  for specialists  to  see product in action.  Yet  we still do not see any real uptake.  Given the story  these things should be flying off the shelf.

Another question might be  'Are  these  items  impacted by  the  current 'chip'  shortage.  Since we are now going to manufacture ourselves  is  the shortage a problem  - Though I guess you need sales  to get to that??

GLTA
<< Previous
Bullboard Posts
Next >>